Plain-English translation of NCT07153939 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Velocity Percutaneous Arterio-Venous Fistula System, a new minimally invasive way to create dialysis access for people with kidney failure. Instead of traditional open surgery, the Velocity System uses a small catheter inserted through the skin to create the connection your body needs for dialysis. Researchers want to see if this newer approach is safe and works as well as traditional surgery, while causing less pain and faster recovery.
People with kidney failure need a reliable access point in their arm for dialysis treatment, which traditionally requires open surgery with longer recovery times. This trial exists to see if a less invasive, catheter-based approach could give patients the same reliable dialysis access with fewer complications and faster healing.
You likely qualify if…
You likely don't qualify if…
If you enroll, you would undergo the Velocity procedure as an outpatient, which involves a catheter inserted through a small puncture in your skin to create the dialysis access. After the procedure, you would return for regular follow-up visits over 5 years that include physical exams, ultrasound scans to check how the access is developing, and dialysis assessments to make sure it's working properly. The study team will monitor you closely for any complications and record any additional procedures you might need to help the access mature or function better.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States